IL77096A - Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors - Google Patents

Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors

Info

Publication number
IL77096A
IL77096A IL77096A IL7709685A IL77096A IL 77096 A IL77096 A IL 77096A IL 77096 A IL77096 A IL 77096A IL 7709685 A IL7709685 A IL 7709685A IL 77096 A IL77096 A IL 77096A
Authority
IL
Israel
Prior art keywords
angiogene
pharmaceutical compositions
growth factors
wound healing
enhancing wound
Prior art date
Application number
IL77096A
Other languages
English (en)
Original Assignee
Curatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curatech Inc filed Critical Curatech Inc
Publication of IL77096A publication Critical patent/IL77096A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Eye Examination Apparatus (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
IL77096A 1984-11-29 1985-11-19 Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors IL77096A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67647184A 1984-11-29 1984-11-29
US78620685A 1985-10-10 1985-10-10

Publications (1)

Publication Number Publication Date
IL77096A true IL77096A (en) 1993-01-31

Family

ID=27101561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77096A IL77096A (en) 1984-11-29 1985-11-19 Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors

Country Status (16)

Country Link
EP (2) EP0383363A3 (fr)
AT (1) ATE78167T1 (fr)
AU (1) AU596954B2 (fr)
CA (1) CA1261259A (fr)
CH (1) CH673774A5 (fr)
DE (2) DE3586355T2 (fr)
DK (1) DK165169C (fr)
FI (1) FI85219C (fr)
GB (1) GB2248777B (fr)
HU (1) HUT42329A (fr)
IE (1) IE57894B1 (fr)
IL (1) IL77096A (fr)
NL (1) NL8520384A (fr)
NO (1) NO170194C (fr)
SE (1) SE8603228L (fr)
WO (1) WO1986003122A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187263A (en) * 1984-10-12 1993-02-16 Zymogenetics, Inc. Expression of biologically active PDGE analogs in eucaryotic cells
EP0487116B1 (fr) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Analogues biologiquement actifs d'un facteur de croissance provenant de plaquettes sanguines dans des cellules eucaryotiques
US5498600A (en) * 1984-10-12 1996-03-12 Zymogenetics, Inc. Biologically active mosaic proteins
US5045633A (en) * 1985-02-25 1991-09-03 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
US5814602A (en) * 1988-03-17 1998-09-29 Novo Nordisk A/S Heparin-binding proteins
US4900541A (en) * 1988-05-06 1990-02-13 Govier William C Sunscreen composition
IT1217938B (it) * 1988-06-28 1990-03-30 Girolamo Sirchia Procedimento per la preparazione e la conservazione di concentrati eritrocitari e piastrinici
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
EP1142581A3 (fr) * 1990-11-27 2002-09-11 American National Red Cross Compositions contenant un agent de scellement tissulaire et des facteurs de croissance, qui accélérent la cicatrisation
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US5171579A (en) * 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
IL105529A0 (en) * 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
EP0637450A3 (fr) * 1993-08-04 1995-04-05 Collagen Corp Méthode et composition pour revigorer le tissu cicatriciel.
AU7988594A (en) * 1993-12-08 1995-06-27 Universite De Montreal Process for the preparation of serum and platelet growth factors extract
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
WO1996037601A1 (fr) * 1995-05-24 1996-11-28 Cellfactors Plc Agents de differenciation cellulaire
WO1996039208A1 (fr) * 1995-06-06 1996-12-12 Quantic Biomedical Partners Dispositif et procede de concentration de plasma
US5834418A (en) * 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
US6120520A (en) * 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US6051008A (en) 1996-12-02 2000-04-18 Angiotrax, Inc. Apparatus having stabilization members for percutaneously performing surgery and methods of use
US6117444A (en) * 1997-04-10 2000-09-12 Brigham & Women's Hospital Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6524568B2 (en) 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
NZ509122A (en) * 1998-06-22 2003-09-26 Cytomedix Inc Wound healant comprising activated growth from platelets and ascorbic acid
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
US8293530B2 (en) 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US8529956B2 (en) 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US20050142208A1 (en) * 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
WO2004024195A1 (fr) 2002-09-10 2004-03-25 American National Red Cross Pansement hemostatique
WO2005105121A1 (fr) * 2004-05-05 2005-11-10 Synthes Gmbh Utilisation de plaquettes ou de plasma riche en plaquettes (prp)
US8529961B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
WO2009020612A1 (fr) 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Procédés et pansement pour refermer des plaies internes
WO2020112963A1 (fr) 2018-11-30 2020-06-04 Cellphire, Inc. Plaquettes en tant qu'agents de livraison
WO2020113090A1 (fr) 2018-11-30 2020-06-04 Cellphire, Inc. Plaquettes utilisées comme agents d'administration
SG11202112054WA (en) 2019-05-03 2021-11-29 Cellphire Inc Materials and methods for producing blood products
AU2020334903B2 (en) 2019-08-16 2023-12-21 Cellphire, Inc. Thrombosomes as an antiplatelet agent reversal agent
CA3170198A1 (fr) 2020-02-04 2021-08-12 Cellphire, Inc Methodes de traitement de l'hemophilie acquise avec des plaquettes chargees anti-fibrinolytiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195061A (en) * 1966-05-27 1970-06-17 Fmc Corp Coated Structures and Methods of Forming Them.
FR2533438B2 (fr) * 1979-12-27 1986-03-07 Sederma Sarl Utilisation en cosmetologie des facteurs de croissance et d'extraits biologiques contenant ceux-ci
FR2472385A1 (fr) * 1979-12-27 1981-07-03 Sederma Sa Nouveaux extraits biologiques utilisables en cosmetologie, et procedes d'obtention de ces extraits
DE3110560A1 (de) * 1981-03-18 1982-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor

Also Published As

Publication number Publication date
DE3586355D1 (de) 1992-08-20
EP0383363A3 (fr) 1990-10-03
EP0202298A1 (fr) 1986-11-26
NO170194C (no) 1992-09-23
DK357386D0 (da) 1986-07-28
ATE78167T1 (de) 1992-08-15
AU596954B2 (en) 1990-05-24
CH673774A5 (fr) 1990-04-12
WO1986003122A1 (fr) 1986-06-05
FI85219C (fi) 1992-03-25
NO862964L (no) 1986-07-23
DK165169B (da) 1992-10-19
EP0202298A4 (fr) 1988-07-04
DE3590594T1 (fr) 1987-01-29
GB2248777A (en) 1992-04-22
GB8617658D0 (en) 1986-08-28
AU5094985A (en) 1986-06-18
FI85219B (fi) 1991-12-13
SE8603228D0 (sv) 1986-07-25
DE3586355T2 (de) 1993-01-14
SE8603228L (sv) 1986-07-25
NO170194B (no) 1992-06-15
FI863087A0 (fi) 1986-07-28
IE57894B1 (en) 1993-05-05
CA1261259A (fr) 1989-09-26
EP0383363A2 (fr) 1990-08-22
HUT42329A (en) 1987-07-28
FI863087A (fi) 1986-07-28
DK165169C (da) 1993-03-01
DK357386A (da) 1986-07-28
GB2248777B (en) 1993-06-30
NO862964D0 (no) 1986-07-23
EP0202298B1 (fr) 1992-07-15
NL8520384A (nl) 1986-10-01
IE852810L (en) 1986-05-29

Similar Documents

Publication Publication Date Title
IL77096A (en) Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors
DK0859596T3 (da) Vækstfaktorholdige gelformuleringer
IL154797A0 (en) Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
NZ222551A (en) A method of healing wounds and a method of regenerating bone; pharmaceutical composition of platelet-derived growth factor and insulin-like growth factor
DE69332350T2 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DE69007964T2 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
DE69009748T2 (de) Fgf enthaltende stabilisierte zubereitungen.
IT1240683B (it) Composizione farmaceutica contenente egf
EP0161816A3 (fr) Urogastrone
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired